Axitinib Has Antiangiogenic and Antitumorigenic Activity in Myxoid Liposarcoma
Myxoid liposarcoma is a rare form of soft-tissue sarcoma. Although most patients initially respond well to treatment, approximately 21% relapse, highlighting the need for alternative treatments. To identify novel treatment regimens and gain a better understanding of myxoid liposarcoma tumor biology,...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Hindawi Limited
2016-01-01
|
| Series: | Sarcoma |
| Online Access: | http://dx.doi.org/10.1155/2016/3484673 |